BRIEF-Innovent Biologics Says Obtained Early Clearance From Federal Trade Commission

Reuters
Yesterday
BRIEF-<a href="https://laohu8.com/S/IVBIY">Innovent Biologics</a> Says Obtained Early Clearance From Federal Trade Commission

March 25 (Reuters) - Innovent Biologics Inc 1801.HK:

  • OBTAINED EARLY CLEARANCE FROM FEDERAL TRADE COMMISSION

  • ALL CONDITIONS PRECEDENT TO EFFECTIVENESS OF STRATEGIC COLLABORATION AGREEMENT BETWEEN LILLY AND CO SATISFIED

  • MEDIA REPORTS HAVE INCORRECTLY INTERPRETATED EFFECTIVENESS OF STRATEGIC COLLABORATION AGREEMENT AS ACQUISITION OF CO

  • CLARIFIES NOT ENGAGED IN PURSUING SUCH TRANSACTION

Further company coverage: 1801.HK

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10